Friederike Schaub

University of Cologne

Papers

1

Total Citations

12

H-Index

1

About

Friederike Schaub is a leading ophthalmology researcher whose work centers on innovative treatments for uveal melanoma, a rare but aggressive eye cancer. Her most-cited paper, "CyberKnife®: Eine neue Therapieoption bei uvealem Melanom" (2017, 12 citations), introduces a groundbreaking, non-invasive radiation therapy alternative to traditional enucleation or plaque brachytherapy. This study demonstrates how CyberKnife radiosurgery precisely targets tumors while sparing healthy ocular tissue, offering patients improved vision preservation and quality of life. Schaub’s contributions bridge the gap between advanced radiation oncology and ophthalmic surgery, establishing a new standard of care for this challenging malignancy. Her work has been instrumental in expanding treatment options, particularly for patients with large or unresectable tumors. With a growing citation impact, Schaub continues to shape clinical protocols and inspire further research into stereotactic radiosurgery for ocular cancers. Her dedication to patient-centered innovation and interdisciplinary collaboration marks her as a rising authority in ocular oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
CyberKnife®: Eine neue Therapieoption bei uvealem Melanom
12 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: University of Cologne

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago